Clinical Trial Update: Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and preliminary efficacy of a cancer medication combined with immune cells in subjects with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• undisclosed

Snippet

Sponsor: Hangzhou Converd Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1 | Status: UNKNOWN